Your session is about to expire
← Back to Search
Stem Cell Research for Melanoma and Head and Neck Cancer
Study Summary
This trial is testing a new platform to learn more about melanoma and head and neck squamous cell cancer to develop better, more individualized treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 118 Patients • NCT00003138Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can take care of myself and am up and about more than half of my waking hours.Your blood, liver, and kidney functions are at normal levels. You have enough red and white blood cells, and your organs are working well. You have measurable disease according to specific criteria, and you can understand and agree to sign a consent form.I have melanoma or head/neck cancer that cannot be cured, but can be biopsied or surgically removed at the University of Colorado Hospital.I don't have allergies to E. coli proteins, sickle cell, severe lung disease, significant spleen issues, active cancer other than melanoma or head/neck cancer, or hepatitis B/C or HIV.I am 21 years old or older.
- Group 1: Melanoma, head and neck
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment still underway for this particular experiment?
"Clinicaltrials.gov has confirmed this study, which was initially posted in mid-May 2015 and most recently updated on June 20th 2022, is actively seeking patients to participate."
What past research has been conducted on this particular treatment approach?
"As of now, 164 clinical studies are underway to evaluate this treatment. Out of those trials, 38 have reached Phase 3 status and the majority are located in Saint Louis, Missouri; although there is a total of 5442 trial sites around the world."
To what maladies is this therapeutic remedy typically applied?
"Febrile neutropenia can be managed with this particular therapy and it may also prove efficacious for treating conditions like myeloablative chemotherapy, infection, and neutropenia."
How many individuals are participating in this investigation?
"Affirmative. According to clinicaltrials.gov, this medical experiment has been ongoing since May 13th 2015 and is actively recruiting participants at the time of writing (June 2022). 40 individuals are sought after from single site."
Share this study with friends
Copy Link
Messenger